What is the price target for TFFP stock?
7 analysts have analysed TFFP and the average price target is 30.6 USD. This implies a price increase of 46976.92% is expected in the next year compared to the current price of 0.065.
TFF Pharmaceuticals Inc (TFFP) Forecast, Price Target & Analyst Ratings
NASDAQ:TFFP • US87241J2033
Current stock price
0.065 USD
-0.1 (-60.05%)
At close:
0.135 USD
+0.07 (+107.69%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TFF Pharmaceuticals Inc (TFFP).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -$0.74
- Revenue Estimate
- 204K
Price Target Details & History
Consensus Price Target and Range
Mean target
$30.60
Upside
+ 46,976.92%
From current price of $0.07 to mean target of $30.60, Based on 7 analyst forecasts
Low
$30.30
Median
$30.60
High
$31.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for TFFP. The average price target is 30.6 USD. This implies a price increase of 46976.92% is expected in the next year compared to the current price of 0.065.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
TFFP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TFFP.
In the previous month the buy percentage consensus was at a similar level.
TFFP was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-03-28 | Roth MKM | Maintains | Buy -> Buy |
| 2023-05-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-22 | JonesTrading | Initiate | Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-03-05 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-08 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -$0.74
- Revenue Estimate
- 204K
- Revenue Q2Q
- 78.43%
- EPS Q2Q
- 62.96%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
166.67%
EPS (1 Month)
0.00%
EPS (3 Months)
22.34%
Next Earnings Summary
The next earnings revenue estimate has been revised upward by 166.67% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 90K | 500K 455.56% | 733.87K 46.77% | 1.176M 60.25% | 816K -30.61% | 11.962M 1,365.93% | |
| EBITDA YoY % growth | -31.68M -69.50% | -31.41M 0.85% | -21.392M 31.89% | 24.174M 213.00% | 23.658M -2.13% | 23.617M -0.18% | |
| EBIT YoY % growth | -31.79M -70.09% | -31.8M -0.03% | -21.895M 31.15% | -19.518M 10.86% | -25.517M -30.74% | -18.604M 27.09% | |
| Operating Margin | -35,322.22% | -6,360.00% | -2,983.45% | -1,659.67% | -3,127.13% | -155.52% | |
| EPS YoY % growth | -1.25 -38.89% | -3.46 -176.80% | -12.51 -261.56% | -4.37 65.10% | -3.85 11.92% | -2.76 28.12% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.74 62.96% | -0.44 81.73% | -0.34 72.41% | -0.29 64.74% | -0.30 60.27% |
| Revenue Q2Q % growth | 204K 78.43% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.864M 9.39% | -8.64M -49.21% | -8.81M -122.32% | -9.104M -154.14% | -9.41M -93.44% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.17%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
153.49%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
45.36%
EBIT Next 5 Year
N/A
TFF Pharmaceuticals Inc / TFFP Forecast FAQ
What are the consensus estimates for TFFP stock next earnings?
The consensus EPS estimate for the next earnings of TFF Pharmaceuticals Inc (TFFP) is -0.74 USD and the consensus revenue estimate is 204.00K USD.
What is the expected long term growth rate for TFF Pharmaceuticals Inc (TFFP)?
The expected long term growth rate for TFF Pharmaceuticals Inc (TFFP) is 153.49%.